Cardiff Oncology, Inc. ( CRDF) - Key Metrics
CRDF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q3 | $0 | -$0.17 | -$0.16 | -$0.16 |
| 2025Q2 | $0 | -$0.21 | -$0.13 | -$0.13 |
| 2025Q1 | $0 | -$0.20 | -$0.19 | -$0.19 |
CRDF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.51 |
| 2025Q3 | ? | -3.06 |
| 2025Q2 | ? | -3.76 |
| 2025Q1 | ? | -3.89 |
CRDF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -11.10% | ? |
| 2025Q4 | -3.18% | ? |
| 2025Q3 | -7.88% | ? |
| 2025Q2 | -3.99% | ? |
| 2025Q1 | -6.12% | ? |
CRDF
Price: $1.40
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.67 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 531000
Market Capitalization: 120.3 million